UPC (Universe Pharmaceuticals) Issuance of Debt: $10.27 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UPC Universe Pharmaceuticals Inc UPC
64 GF Score
Price $4.62
GF Value $5.17
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Universe Pharmaceuticals Issuance of Debt?

Universe Pharmaceuticals UPC +5.72% 64 Issuance of Debt is $10.27 Mil as of Sep. 2025. GuruFocus rates UPC with a GF Score™ of 64/100 and a GF Value™ of $5.17 (Modestly Undervalued). The stock has 7 warning signs investors should review.

Universe Pharmaceuticals's Issuance of Debt for the six months ended in Sep. 2025 was $8.18 Mil.

Universe Pharmaceuticals's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2025 was $10.27 Mil.

Universe Pharmaceuticals Issuance of Debt Related Terms

Universe Pharmaceuticals Issuance of Debt Historical Data

* Premium members only.

The historical data trend for Universe Pharmaceuticals's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universe Pharmaceuticals Issuance of Debt Chart

Universe Pharmaceuticals Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Issuance of Debt
Get a 7-Day Free Trial 5.21 11.86 14.88 17.32 10.27

Universe Pharmaceuticals Semi-Annual Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.98 7.18 10.14 2.09 8.18
UPC
64GF Score
Universe Pharmaceuticals Inc UPC
Issuance of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Universe Pharmaceuticals Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $10.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Issuance of Debt →
What does a Issuance of Debt of $10.27 Mil mean?
Universe Pharmaceuticals (UPC) has a Issuance of Debt of $10.27 Mil as of Sep. 2025. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Universe Pharmaceuticals and its competitors.
Is Universe Pharmaceuticals' Issuance of Debt too high?
Universe Pharmaceuticals' current Issuance of Debt is $10.27 Mil. Overall, Universe Pharmaceuticals has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' Issuance of Debt compare to CPMD and SHPH?
Universe Pharmaceuticals' Issuance of Debt of $10.27 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Issuance of Debt for a Drug Manufacturers company?
A good Issuance of Debt depends on the Drug Manufacturers industry context. However, Issuance of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Issuance of Debt mean?
A high Issuance of Debt can signal that a stock is expensive relative to its fundamentals. Issuance of Debt is all the cash inflow from debt, including both long-term debt and short-term debt. View historical data on Universe Pharmaceuticals and its competitors. Universe Pharmaceuticals's current Issuance of Debt is $10.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Modestly Undervalued. The stock's GF Value™ is $5.17, compared to a current price of $4.62 — trading 10.6% below its estimated fair value. The current Issuance of Debt is $10.27 Mil. Universe Pharmaceuticals' overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Issuance of Debt calculated?
Issuance of Debt is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current Issuance of Debt is $10.27 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universe Pharmaceuticals (UPC) Overvalued in 2026?

Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be undervalued. The current stock price of $4.62 is trading 10.6% below its estimated GF Value™ of $5.17. GuruFocus considers Universe Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for UPC:

  • Issuance of Debt: $10.27 Mil
  • GF Value™: $5.17 vs. price of $4.62 (10.6% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universe Pharmaceuticals Business Description

Address 265 Jingjiu Avenue, Jinggangshan Economic & Technological Development Zone, Jiangxi, Ji’an, CHN, 343100
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
64GF Score

Get the complete analysis for UPC

Issuance of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.62
Price
$5.17
GF Value